TY  - RPRT
TI  - Safety and immunogenicity of an mRNA COVID-19 vaccine administered to adults: A phase 2, randomized, active-controlled trial.
AU  - Robynne Wong
AU  - Anastasia Kuznetsova
AU  - Emna Baba
AU  - Tapiwa Ganyani
AU  - Stefano Berrè
AU  - Philippe Boutet
AU  - Roshan Ramanathan
AU  - Dominic Douglas
AU  - Philipp Mann
AU  - Martin Robert Gaudinski
PY  - 2026
DO  - 10.1080/21645515.2026.2715900
UR  - https://pubmed.ncbi.nlm.nih.gov/42647564/
ID  - 42647564
ER  -